<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13402">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02932449</url>
  </required_header>
  <id_info>
    <org_study_id>TARGET-PBC</org_study_id>
    <nct_id>NCT02932449</nct_id>
  </id_info>
  <brief_title>A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis</brief_title>
  <official_title>A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Target PharmaSolutions, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Target PharmaSolutions, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 5-year, longitudinal, observational study of patients with PBC designed to
      specifically address important clinical questions that remain incompletely answered from
      registration trials. In addition to the study database, a bio specimen repository will also
      be included so that translational studies of genomics and biomarkers of response may be
      performed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate PBC treatment regimens being used in clinical practice</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine populations underrepresented in phase III clinical trials</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine biochemical response and its association with long term outcomes</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimate adverse event frequency and severity and describe management practices</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Biliary Cirrhosis, Primary</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Participants enrolled in TARGET-PBC will be invited to participate in the optional
      Biorepository Specimen Bank (BSB). Blood samples for biomarker and DNA/RNA assays will be
      collected on a voluntary basis and participation in this project will not affect
      participation in the main study.

      Blood samples for exploratory genetic and biomarker studies can be used for research
      purposes to identify potential biomarkers predictive of PBC diagnosis, assess correlates of
      response to PBC treatment (in terms of mode of action, efficacy, dose, safety and
      tolerability), understand factors influencing disease progression, determine how best to
      monitor and treat PBC, aid in the development of a new medical products, or explore
      complications of PBC and treatment.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        adults with PBC who are being seen specifically to address this disease process
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (age 18 or older) being treated or managed for PBC

        Exclusion Criteria:

          -  Inability to provide written informed consent

          -  Simultaneous enrollment in another prospective registry or clinical trial or study
             where PBC treatment outcomes are reported, except where approved or conducted as an
             adjunct project of TARGET-PBC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laura Malahias</last_name>
    <phone>984-234-0268</phone>
    <email>lmalahias@targetpharmasolutions.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gastro Florida</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33762</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Brewington, CRC</last_name>
      <phone>727-336-7682</phone>
      <email>sbrewington@gastrofl.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida Hepatology Research</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angie Bauer</last_name>
      <phone>352-273-9512</phone>
      <email>bauera@medicine.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SCFLD/University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Cottone</last_name>
      <phone>305-243-1104</phone>
      <email>cxc1335@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center, GI Research</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veronica Kflu</last_name>
      <phone>410-576-5485</phone>
      <email>vkflu@mdmercy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jo Ann Filla-Taylor</last_name>
      <phone>314-977-7525</phone>
      <email>fillatj@slu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Nebraska</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Fletcher</last_name>
      <phone>402-552-6120</phone>
      <email>amanda.fletcher@unmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sandra Atlas Bass Center for Liver Diseases</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radica Palmer, NP</last_name>
      <phone>516-562-2082</phone>
      <email>rpalmer@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Liver Disease and Transplant at CMC</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gale Groseclose</last_name>
      <phone>704-355-4875</phone>
      <email>gale.groseclose@carolinashealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pinnacle Clinical Research</name>
      <address>
        <city>Live Oak</city>
        <state>Texas</state>
        <zip>78233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Bon Secours Liver Institute of Virginia</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Soublet, LPN</last_name>
      <phone>757-947-3190</phone>
      <email>joyce_soublet@bshsi.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Nguyen</last_name>
      <phone>206-744-3402</phone>
      <email>phnmedic@uw.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 27, 2017</lastchanged_date>
  <firstreceived_date>September 7, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Liver Cirrhosis, Biliary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
